Jeffrey L. Ambroso

Preclinical Strategy to Reduce Clinical Hepatotoxicity Using in Vitro Bioactivation Data for >200 Compounds

Melanie Z. Sakatis, Melinda J. Reese, Andrew W. Harrell et al. · Chemical Research in Toxicology · 2012 · 121 citations

Pharmacy, Pharmacology, Toxicology +17

Developmental toxicity of di-isodecyl and di-isononyl phthalates in rats

Stacey J. Waterman, Jeffrey L. Ambroso, Laura Keller et al. · Reproductive Toxicology · 1999 · 61 citations

Pharmacy, Pharmacology, Toxicology +14

In vitro embryotoxicity of the cysteine proteinase inhibitors benzyloxycarbonyl‐phenylalanine‐alanine‐diazomethane (Z‐Phe‐Ala‐CHN₂) and benzyloxycarbony1‐phenylalanine‐phenylalanine‐diazomethane (Z‐Phe‐Phe‐CHN₂)

Jeffrey L. Ambroso, Craig Harris · Teratology · 1994 · 33 citations

Life Sciences, Pharmacology, Toxicology +11

An integrated reactive metabolite evaluation approach to assess and reduce safety risk during drug discovery and development

Melinda J. Reese, Melanie Z. Sakatis, Jeffrey L. Ambroso et al. · Chemico-Biological Interactions · 2010 · 29 citations

Pharmacy, Pharmacology, Toxicology +16

Lymphocyte Loss and Immunosuppression Following Acetaminophen-Induced Hepatotoxicity in Mice as a Potential Mechanism of Tolerance

Mary Jane Masson, Richard A. Peterson, Christine Chung et al. · Chemical Research in Toxicology · 2006 · 29 citations

Life Sciences, Immunology, Toxicology +17